Behavioral counseling and varenicline treatment for smoking cessation
- PMID: 20409497
- PMCID: PMC2879135
- DOI: 10.1016/j.amepre.2010.01.024
Behavioral counseling and varenicline treatment for smoking cessation
Abstract
Background: Smoking remains the primary preventable cause of death and illness in the U.S. Effective, convenient treatment programs are needed to reduce smoking prevalence.
Purpose: This study compared the effectiveness of three modalities of a behavioral smoking-cessation program in smokers using varenicline.
Methods: Current treatment-seeking smokers (n=1202) were recruited from a large healthcare organization between October 2006 and October 2007. Eligible participants were randomized to one of three smoking-cessation interventions: web-based counseling (n=401); proactive telephone-based counseling (PTC; n=402); or combined PTC and web counseling (n=399). All participants received a standard 12-week FDA-approved course of varenicline. Self-report determined the primary outcomes (7-day point prevalent abstinence at 3- and 6-month follow-ups); the number of days varenicline was taken; and treatment-related symptoms. Behavioral measures determined utilization of both the web- and Phone-based counseling.
Results: Intent-to-treat analyses revealed relatively high percentages of abstinence at 3 months (38.9%, 48.5%, 43.4%) and at 6 months (30.7%, 34.3%, 33.8%) for the web, PTC, and PTC-web groups, respectively. The PTC group had a significantly higher percentage of abstinence than the web group at 3 months (OR=1.48, 95% CI=1.12, 1.96), but no between-group differences in abstinence outcomes were seen at 6 months.
Conclusions: Phone counseling had greater treatment advantage for early cessation and appeared to increase medication adherence, but the absence of differences at 6 months suggests that any of the interventions hold promise when used in conjunction with varenicline.
2010 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Nicotine receptor partial agonists for smoking cessation.Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006103. doi: 10.1002/14651858.CD006103.pub6. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2016 May 09;(5):CD006103. doi: 10.1002/14651858.CD006103.pub7. PMID: 22513936 Updated. Review.
-
Internet versus in-person counseling for patients taking varenicline for smoking cessation.Mil Med. 2013 Apr;178(4):401-5. doi: 10.7205/MILMED-D-12-00272. Mil Med. 2013. PMID: 23707824 Clinical Trial.
-
Varenicline versus transdermal nicotine patch: a 3-year follow-up in a smoking cessation clinic in Taiwan.Psychopharmacology (Berl). 2014 Jul;231(14):2819-23. doi: 10.1007/s00213-014-3482-9. Epub 2014 Feb 13. Psychopharmacology (Berl). 2014. PMID: 24522334 Clinical Trial.
-
[Effectiveness of Varenicline with counseling programs on smoking cessation in a targeted clinical setting in China].Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Dec;35(12):1349-53. Zhonghua Liu Xing Bing Xue Za Zhi. 2014. PMID: 25623452 Chinese.
-
Nicotine receptor partial agonists for smoking cessation.Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006103. doi: 10.1002/14651858.CD006103.pub6. PMID: 21328282 Updated. Review.
Cited by
-
Real-Life Effectiveness of Smoking Cessation Delivery Modes: A Comparison Against Telephone Counseling and the Role of Individual Characteristics and Health Conditions in Quit Success.Nicotine Tob Res. 2024 Mar 22;26(4):452-460. doi: 10.1093/ntr/ntad195. Nicotine Tob Res. 2024. PMID: 37930890 Free PMC article.
-
Nicotine receptor partial agonists for smoking cessation.Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8. Cochrane Database Syst Rev. 2023. PMID: 37142273 Free PMC article. Review.
-
Consideration of sex and gender differences in addiction medication response.Biol Sex Differ. 2022 Jun 27;13(1):34. doi: 10.1186/s13293-022-00441-3. Biol Sex Differ. 2022. PMID: 35761351 Free PMC article. Review.
-
Barriers to Building More Effective Treatments: Negative Interactions Amongst Smoking Intervention Components.Clin Psychol Sci. 2021 Nov 1;9(6):995-1020. doi: 10.1177/2167702621994551. Epub 2021 Apr 26. Clin Psychol Sci. 2021. PMID: 35003904 Free PMC article.
-
Tobacco quitline engagement and outcomes among primary care patients reporting use of tobacco or dual tobacco and cannabis: An observational study.Subst Abus. 2021;42(4):417-422. doi: 10.1080/08897077.2020.1846665. Epub 2020 Dec 3. Subst Abus. 2021. PMID: 33270541 Free PMC article.
References
-
- Stead LF, Perera R, Lancaster T. Telephone counseling for smoking cessation. Cochrane Database Syst Rev. 2006;3:CD002850. - PubMed
-
- Fiore MC, Jaén CR, Baker TB, et al. Clinical Practice Guideline. Rockville, MD: USDHHS. Public Health Service; May, 2008. Treating Tobacco Use and Dependence: 2008 Update.
-
- Graham AL, Cobb NK, Raymond L, Sill S, Young J. Effectiveness of an Internet-based worksite smoking cessation intervention at 12 months. J Occup Environ Med. 2007;49(8):821–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
